MT Harbinson

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
More than half of those born after 1960 will develop cancer during their lifetime. Fortunately, owing to improved diagnosis and treatment, cure rates have risen steadily over the last three decades. With an increased survivorship, more will experience adverse effects of cancer therapeutics on the heart. As the oncologist's focus begins to encompass the(More)
Hydroxymethylglutaryl-coenzyme A (HMG CoA) reductase inhibitors (statins) are now one of the most widely prescribed medications worldwide, with an estimated 2 million people in the UK 1 and more than 18 million people in the USA currently taking a statin. 2 From their development in the 1970s the impact of statins on the treatment of cardiovascular disease(More)
4.05pm Two case presentations from Erne Hospital 4.20pm Invited Abstract: " The patient with neurological symptoms-pathological or functional? " Dr SA Hawkins, Consultant Neurologist and Reader in Medicine, Royal Victoria Hospital and Queens University Belfast. Objective: To estimate the prevalence of multiple sclerosis (MS). Background: NI has been(More)
  • 1